Einige Inhalte dieser Seite sind nur für Abonnenten sichtbar.       Anmelden     oder      Jetzt abonnieren!

Archiv: Alle Kategorien

Logitech - From Science Fiction to the Boardroom: Logitech Previews Breakthrough Sound Shape Audio Technology in New Rally Speakers 2 Pro and Max » Report
Logitech - Logitech Unveils Its Biggest Enterprise Launch Ever: More Power, More Future-Proofed Rooms for the AI Revolution » Report
Logitech - Q2 Financial Results for FY 2027 » Report
Guten Abend: Daily SMI -1,24% 13637 +++ Top NESN +0,6% GALD +0,1% ZURN flat GIVN PGHN -0,3% GEBN -0,8% Flop CFR LONN -2,4% ROP SDZ -2% NOVN -1,9% SIKA -1,7% +++ VSMI +3,07% 16.24 +++ DAX -1,18% 24806 +++ Strasse nachgebend
Nestlé S.A. Coming soon: 2026 third-quarter and nine-month sales » Report
WISeSat.Space and FOSSA Systems Confirm October 2026 Satellite Launch, Advancing the QSOC Constellation Roadmap » Report
SCHWEIZER INDIKATIONEN: Der SMI notiert vorbörslich leichter. Nachgebende Alcon, Amrize, Novartis, Sandoz, Sika, Swisscom, schwache AMS Osram, feste Emmi, Sonova fallen auf. Meist stabil tendieren die übrigen gehandelten Titel. Quelle cash Insider
Fall Clinical 2026: Galderma presents new three-year Nemluvio® data showing deep and lasting skin lesion and itch responses in patients with atopic dermatitis aged 12 and older » Galderma
Mobimo Holding AG Press release: Ground-breaking ceremony for 122 apartments in the Nordbau » Report
Mobimo Holding AG Communiqué: Pose de la première pierre pour les 122 appartements dans le Nordbau » Report
Mobimo Holding AG Medienmitteilung: Grundsteinlegung für 122 Wohnungen im Nordbau » Report
Newron Pharmaceuticals S.p.A. - Newron Provides Update on FDA Clinical Hold and Phase 3 ENIGMA-TRS Development Program » Report
Newron Pharmaceuticals S.p.A. - Newron gibt Update zum klinischen Hold durch die FDA und zum Phase 3 – Entwicklungsprogramm ENIGMA-TRS » Report
UBS Business Solutions AG - The Art Basel and UBS Survey of Global Collecting 2026 reveals Gen Z as the highest-spending generation » Report
UBS Business Solutions AG - Die Art Basel and UBS Survey of Global Collecting 2026 zeigt: Die Generation Z gibt am meisten für Kunst aus » Report
Zealand Pharma announces positive Phase 2 ZUPREME-2 topline results for amylin analog petrelintide in people with overweight or obesity and type 2 diabetes » Report
Novartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU) » Report
Guten Abend: Daily SMI +0,14% 13808 +++ Top ROP +2,9% NOVN +2,4% SDZ +1,4% GALD +0,8% SREN NESN +0,5% Flop HOLN ABBN -3,3% UBSG -3,1% PGHN -3% AMRZ -2,7% GEBN -1,6% +++ VSMI +0,18% 15.75 +++ DAX -1,35% 25104 +++ Strasse nachgebend bis schwächer
WISeSat.Space to Ring the Nasdaq Opening Bell on October 9 and Highlight Secure Space Infrastructure Strategy at Convene Quantum Space Security Roundtable » Report
Novartis advances multiple sclerosis innovation with late-breaking remibrutinib and broad portfolio data at MSToronto2026 » Report